المؤلفون: Farnier M; Point Médical, Rond Point de la Nation, Dijon, France. Electronic address: michelfarnier@nerim.net.

المصدر: Atherosclerosis. Supplements [Atheroscler Suppl] 2015 Feb; Vol. 17, pp. 2-8.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100973461 Publication Model: Print Cited Medium: Internet ISSN: 1878-5050 (Electronic) Linking ISSN: 15675688 NLM ISO Abbreviation: Atheroscler Suppl Subsets: MEDLINE

مواضيع طبية MeSH: Azetidines/*therapeutic use , Diabetes Mellitus, Type 2/*epidemiology , Dyslipidemias/*drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Simvastatin/*therapeutic use, Azetidines/adverse effects ; Biomarkers/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/diagnosis ; Drug Combinations ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Ezetimibe, Simvastatin Drug Combination ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Lipids/blood ; Simvastatin/adverse effects ; Treatment Outcome